Journey Medical (DERM) Cash & Current Investments (2020 - 2026)
Journey Medical's (DERM) quarterly Cash & Current Investments came in at $27.2 million in Q1 2026, up 29.18% YoY from $21.1 million in Q1 2025, and up 12.94% on a QoQ basis from $24.1 million in Q4 2025.
Journey Medical (DERM) Cash & Current Investments (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Cash & Current Investments data on file, last reported at $27.2 million in Q1 2026.
- Quarterly Cash & Current Investments rose 29.18% year-over-year to $27.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.2 million (up 29.18% YoY) and the FY2025 annual result came in at $24.1 million, up 18.69% from the prior year.
- Cash & Current Investments climbed to $27.2 million in Q1 2026, from $24.1 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $41.3 million in Q1 2022 to a low of $17.0 million in Q2 2023.
- A 5-year average of $26.5 million and a median of $24.7 million in 2023 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 60.87% — and 2023, when it tumbled 55.43%.
- Tracing DERM's Cash & Current Investments over 5 years: stood at $32.0 million in 2022, then dropped by 14.25% to $27.4 million in 2023, then slipped by 26.0% to $20.3 million in 2024, then increased by 18.69% to $24.1 million in 2025, then advanced by 12.94% to $27.2 million in 2026.
- The last three Cash & Current Investments figures came in at $27.2 million (Q1 2026), $24.1 million (Q4 2025), and $24.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | 25.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.64 Mn |
| Mar 31, 2026 | 27.22 Mn |
| Dec 31, 2025 | 24.10 Mn |
| Sep 30, 2025 | 24.95 Mn |
| Jun 30, 2025 | 20.30 Mn |
| Mar 31, 2025 | 21.07 Mn |
| Dec 31, 2024 | 20.31 Mn |
| Sep 30, 2024 | 22.46 Mn |
| Jun 30, 2024 | 23.90 Mn |
| Mar 31, 2024 | 24.10 Mn |
| Dec 31, 2023 | 27.44 Mn |
| Sep 30, 2023 | 24.75 Mn |
| Jun 30, 2023 | 16.98 Mn |
| Mar 31, 2023 | 26.10 Mn |
| Dec 31, 2022 | 32.00 Mn |
| Sep 30, 2022 | 34.89 Mn |
| Jun 30, 2022 | 38.10 Mn |
| Mar 31, 2022 | 41.30 Mn |
| Dec 31, 2021 | 49.08 Mn |
| Sep 30, 2021 | 21.69 Mn |